- Home
- Share
- Forum
- General forums
- Treatments for type 1 diabetes treatments
- 'World first' trial in Cardiff for new treatment for Type 1 diabetes
'World first' trial in Cardiff for new treatment for Type 1 diabetes
- 89 views
- 7 times supported
- 15 comments
All comments
Go to the last comment
lesmal
AmbassadorGood advisor
lesmal
Ambassador
Joined in 2018
Wishing you every success with this study and may this new drug help with the regrowth of insulin!
This would save so much time and effort with those who have to inject themselves with insulin daily... It would be so much easier to 'pop a pill'!
Hoping eight adult volunteers can be found soon to take part in this great clinical trial!
See the signature
Les
JosephineO
Community managerGood advisor
JosephineO
Community manager
Joined in 2018
@lesmal Yes, it would be great to change the method that diabetes sufferers can receive their insulin and make it easier for them.
It will be interesting to see how this study advances.
See the signature
Josephine, Community Manager
JaneHewitt
Good advisor
JaneHewitt
Joined in 2017
I would be very interested in taking part in this trial, if anyone from the team can contact me, my email address is janehewitt50@sky.com
Mark_O
Mark_O
Joined in 2017
This is very exciting. Hope eight volunteers have been found, if not? Young 48 year old (me) would definitely be willing to move to Cardiff to get involved. Good luck
See the signature
Mark Oldham
John Heathershaw
Good advisor
John Heathershaw
Joined in 2015
I would be very interested in having a trial of this treatment. I have been a Type 1 diabetic for 47 years, so any alternative treatment would be exciting.
Unregistered member
I would be very interested my email is kellykoa2012@yahoo.co.uk
Unregistered member
My email is kellykoa2012@yahoo.co.uk forgot to put 33yrs type 1
JaneHewitt
Good advisor
JaneHewitt
Joined in 2017
I forgot to say I have been diabetic since age 11, and I am now 68, so would certainly be willing to one of the volunteers janehewitt50@sky.com
JaneHewitt
Good advisor
JaneHewitt
Joined in 2017
@lesmal I do not mind being a volunteer for this
lesmal
AmbassadorGood advisor
lesmal
Ambassador
Joined in 2018
@JaneHewitt I'm not the one looking for volunteers... Perhaps contact @JosephineO for more details!
See the signature
Les
Give your opinion
Survey
Articles to discover...
04/05/2024 | Advice
How to get rid of Endocrine Disruptors hiding in your household?
29/04/2024 | Nutrition
27/04/2024 | News
26/04/2024 | News
12/11/2019 | Procedures & paperwork
21/01/2015 | News
14/10/2016 | News
Opioids Causing Concerns, Problems for Chronic Pain Patients
21/10/2014 | News
Subscribe
You wish to be notified of new comments
Your subscription has been taken into account
JosephineO
Community managerGood advisor
JosephineO
Community manager
Joined in 2018
A 'ground-breaking' clinical trial has been launched in Cardiff to help prevent and manage Type 1 diabetes.
The Clinical Research Facility at Cardiff and Vale University Health Board has dosed the first patient in the world with the new investigational drug. It aims to help the regrowth of insulin making ‘beta’ cells of the pancreas, which are lost in patients living with the disease.
Type 1 diabetes is a serious, lifelong condition where blood glucose levels are too high because the body cannot make a hormone called insulin. Those with Type 1 diabetes are dependent on insulin but if this clinical trial works, the regrowth - or regeneration - of beta cells may mean those with Type 1 diabetes becoming far less dependent on insulin injections.
So far, the drug appears to have had no major side-effects, but it is too early to say if it has been effective. The Cardiff team is hoping to attract up to eight adult volunteers to take part in the clinical trial who have had diabetes for more than two years.
"Despite everything achieved in diabetes care, advances in prevention haven’t really occurred. More insulin-producing beta cells are needed for those with this form of diabetes and it is estimated that 90% of patients with Type 1 diabetes have less", added Dr Mohammad Alhadj Ali.
Would you be interesting in trialing this medication?